Krishna Institute of Medical Sci. will hold a meeting of the Board of Directors of the Company on 16 May 2024.Powered by Capital Market - Live News

Krishna Institute of Medical Sciences has received revision in credit ratings from CRISIL as under:Long term rating - CRISIL AA/ Stable (upgraded from CRISIL AA-/ Positive) Short term rating - CRISIL A1+ (reaffirmed) Powered by Capital Market - Live News

Krishna Institute of Medical Sciences has entered into a definitive agreement for the acquisition of land on a 99-year lease and purchase of the building thereon for setting up a new Hospital at Thane. The investment in the project is expected to be around Rs. 500 crore. The purchase of the building and lease amount will be paid from bank loan and internal accruals. It would be a multi-specialty hospital with state-of-the-art tertiary and quaternary care facilities having a land area of approximately 2.59 Acres and a total built-up area of 2.72 Lakh sq. ft. The proposed hospital will have a bed capacity of 300 beds (approx.). This will be the first hospital of KIMS in the Mumbai-Thane region and the third in Maharashtra, following its presence in Nagpur and Nashik. The Nashik unit will be opening in Q1 FY25.Powered by Capital Market - Live News

Net profit of Krishna Institute of Medical Sciences declined 5.45% to Rs 71.84 crore in the quarter ended December 2023 as against Rs 75.98 crore during the previous quarter ended December 2022. Sales rose 7.77% to Rs 605.84 crore in the quarter ended December 2023 as against Rs 562.16 crore during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales605.84562.16 8 OPM %24.2626.89 - PBDT137.83146.11 -6 PBT102.45112.82 -9 NP71.8475.98 -5 Powered by Capital Market - Live News

Krishna Institute of Medical Sciences announced the cessation of Rajeswara Rao Gandu (DIN: 05339318) as Independent Director of the company on completion of his second tenure with effect from 24 January 2024. Powered by Capital Market - Live News